{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-014569","form_type":"8-K","ticker":"ZBH","cik":"0001136869","company_name":"ZIMMER BIOMET HOLDINGS, INC.","filed_at":"2025-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.016629+00:00","generated_at":"2026-05-27T06:29:33.482537+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Zimmer Biomet to acquire Paragon 28 for $1.2B enterprise value, $13/share cash plus CVR","bullets":["Upfront $13.00 per share cash (~$1.1B equity); CVR up to $1.00/share if FY2026 net sales exceed $346M.","Paragon 28 FY2024 revenue $255.9–$256.2M (+18.2–18.4% YoY); targets ~$5B foot & ankle segment growing high-single digits.","Deal ~3% dilutive to ZBH adj. EPS in 2025, ~1% dilutive in 2026, accretive within 24 months; close H1 2025 subject to approvals.","Unanimous board approval; Goldman Sachs advising ZBH, Piper Sandler advising Paragon 28."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-014569","json":"https://secwatch.observer/filing/0001193125-25-014569.json","markdown":"https://secwatch.observer/filing/0001193125-25-014569.md","text":"https://secwatch.observer/filing/0001193125-25-014569.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525014569/0001193125-25-014569-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1136869/000119312525014569/d644888d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T06:29:33.482537+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}